Salmex® is an inhaler with two active substances – fluticasone propionate and salmetrol – with three forms of presentation:
– Dosage 50ug + 100ug
– Dosage 50ug + 250ug
– Dosage 50ug + 500ug
– Salmeterol – Long-acting bronchodilator used to treat and prevent bronchoconstriction in patients with reversible obstructive airway disease.
– Fluticasone – Inhaled corticosteroid used in bronchial asthma for the control of airway inflammation.
– Maintenance treatment of reversible obstructive respiratory disease in adults and children (asthma);
– Maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.